Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Angiogenesis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT00574275
What this trial is testing

Aflibercept Compared to Placebo in Term of Efficacy in Patients Treated With Gemcitabine for Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasm
Sanofi 546
Not applicableStudy completedNCT07843173
What this trial is testing

Peri-implantation Abstinence and Placental Health

Who this might be right for
Placental Development Pregnancy Outcome
Universiti Sains Malaysia 94
Large-scale testing (Phase 3)Study completedNCT00524849
What this trial is testing

Zometa and Circulating Vascular Endothelial Growth Factor (VEGF) in Breast Cancer Patients With Bone Metastasis

Who this might be right for
Metastatic Breast CancerBone Metastases
Fudan University 60
Not applicableNot Yet RecruitingNCT07692477
What this trial is testing

Molecular Characterization of Tumor-Microenvironment Interactions to Predict Drug Resistance in Gastric and GEJ Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma (Siewert II-III)
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 250
Not applicableUnknownNCT00166985
What this trial is testing

The Role of Functional MRI and Doppler Sonography in Assessing Blood Vessel Formation Within the Tumors of Endometrial Cancer Patients

Who this might be right for
Endometrial Cancer
National Taiwan University Hospital 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05859217
What this trial is testing

Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1)

Who this might be right for
Lung CancerNSCLC Stage IVMetastatic NSCLC - Non-Small Cell Lung Cancer+1 more
Jun Zhang, MD, PhD 40
Testing effectiveness (Phase 2)UnknownNCT04446091
What this trial is testing

A Clinical Study of Exploring Camrelizumab in the Treatment of Colorectal Mucinous Adenocarcinoma(MAC)

Who this might be right for
Colorectal Cancer
Zhejiang Cancer Hospital 40
Not applicableStudy completedNCT03519542
What this trial is testing

Epidemiological Study to Identify Prognosis and Predictive Biomarkers for Advanced or Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Spanish Oncology Genito-Urinary Group 62
Post-approval studies (Phase 4)Study completedNCT01952756
What this trial is testing

Effect of Cilostazol Endothelial Progenitor Cells and Collateral Formation in Peripheral Occlusive Artery Disease (PAOD)

Who this might be right for
Peripheral Arterial Diseases
National Cheng-Kung University Hospital 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04480619
What this trial is testing

Safety and Efficacy of Ga68-IAC PET/CT for Diagnosis and Clinical Management in Metastatic Breast Cancer Patients

Who this might be right for
Angiogenic Breast Cancer
Advanced Imaging Projects, LLC 25
Testing effectiveness (Phase 2)Ended earlyNCT01602471
What this trial is testing

[F-18] RGD-K5 Positron Emission Tomography (PET) in Participants With Carotid Artery Stenosis

Who this might be right for
Carotid Stenosis
Siemens Molecular Imaging 5
Early research (Phase 1)Ended earlyNCT00747305
What this trial is testing

Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By Surgery

Who this might be right for
Kidney Cancer
Harry Drabkin 17
Not applicableStudy completedNCT01429467
What this trial is testing

Glucose Variability in Type 1 Diabetes and Its Effect on Factors That Influence New Vessel Formation

Who this might be right for
Type 1 Diabetes
University of Dundee 35
Testing effectiveness (Phase 2)Study completedNCT00635193
What this trial is testing

Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin)

Who this might be right for
Ovarian Cancer, Primary Peritoneal Cancer
AbbVie (prior sponsor, Abbott) 138
Testing effectiveness (Phase 2)Ended earlyNCT02325349
What this trial is testing

PET/CT Imaging of Angiogenesis in Lung or Head and Neck Cancers Prior or During Chemotherapy With Antiangiogenic Agents

Who this might be right for
Advanced Head and Neck CarcinomaAdvanced Non-small Cell Lung Carcinoma
Assistance Publique - Hôpitaux de Paris 1
Testing effectiveness (Phase 2)Looking for participantsNCT06646198
What this trial is testing

TIPS Plus Half-dose Donafenib in AHCC with PVTT-associated Portal Hypertension

Who this might be right for
Hepatocellular Carcinoma with PVTT
Fei Gao 40
Early research (Phase 1)Study completedNCT00654758
What this trial is testing

A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-line, Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
AbbVie 33
Not applicableStudy completedNCT00010114
What this trial is testing

Genetic Study of Newly Diagnosed Central Nervous System Tumors in Young Children

Who this might be right for
Central Nervous System Embryonal Neoplasm
Pediatric Brain Tumor Consortium 83
Not applicableStudy completedNCT00646555
What this trial is testing

Inflammatory Breast Cancer, Tumor Markers, and Factors Associated With Angiogenesis

Who this might be right for
Breast Neoplasms
National Cancer Institute (NCI) 300
Not applicableStudy completedNCT00668473
What this trial is testing

Angiogenic/Angiostatic Mediators in Patients With Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
University of Michigan 30
Next Page